Other widely used biomarkers for prognosis are those found on lung cancer tissue, such as ALK, mesenchymal–epithelial transition (MET), C-ros oncogene 1 (ROS1), or tumor protein p53 (TP53), although with ambiguous yield [290,299]. This evidence concerns the gene TP53 and lung carcinoma.